Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | OxyContin 30mg modified-release tablets (Napp Pharmaceuticals Ltd) |
| BNF code | 0407020ADBCAHAR |
| Virtual Medicinal Product | Oxycodone 30mg modified-release tablets |
| Name | OxyContin 30mg modified-release tablets |
| Supplier | Napp Pharmaceuticals Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Oral |
| Actual Medicinal Product Packs | |
| OxyContin 30mg modified-release tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets | |
dm+d data retrieved from TRUD: release NHSBSA_5.0.0_20250505000001, imported on 5th May 2025 at 04:58:39.